# BioLineRx Ltd.: Form 6-K, filed Sep 11, 2023

- Company: [BioLineRx Ltd.](/companies/blrx.md) (CIK 1498403)
- Form: 6-K
- Filed: 2023-09-11
- Accepted by EDGAR: Sep 11, 2023, 11:07 ET
- Period: 2023-09-11
- Accession: 0001178913-23-003111
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1498403/000117891323003111/zk2330282.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1498403/000117891323003111/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1498403/000117891323003111/zk2330282.htm

Filed Sep 11, 2023.
Source: SEC EDGAR, the filing index for accession 0001178913-23-003111. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
